Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00550394 · ClinicalTrials.gov registry record · Phase 4
Efficacy and Tolerability of Topiramate in Treatment of Bipolar Mania and Alcohol Use in Adolescents and Young Adults
A Phase 4 study, sponsored by University of Cincinnati.
- Completed
- Registry status
- Phase 4
- Development phase
- 56
- Enrollment target
NCT00550394 is a Phase 4 study that has completed, run by University of Cincinnati. The registered enrollment target is 56 participants.
The verdict
NCT00550394, a Phase 4 study, has completed, sponsored by University of Cincinnati.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 56 participants
- Enrollment target
Study Summary
The purpose of this research study is to study the effects (both good and bad) of combining quetiapine and topiramate for treating symptoms of bipolar mania (an illness with periods of elation, excessive excitement, irritability, high energy, racing thoughts, poor sleep, poor judgment, reckless behavior) and to study the effects (both good and bad) of combining quetiapine and topiramate for reducing use of alcohol.
Interventions
- DRUG Quetiapine and Topiramate
- DRUG quetiapine and placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2008-04 |
| Est. Completion | 2010-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00550394
The ClinicalTrials.gov registry entry for NCT00550394 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Cincinnati, which has 245 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Quetiapine and Topiramate is the first listed.
NCT00550394 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00550394 about?
NCT00550394 is a clinical study titled "Efficacy and Tolerability of Topiramate in Treatment of Bipolar Mania and Alcohol Use in Adolescents and Young Adults". The purpose of this research study is to study the effects (both good and bad) of combining quetiapine and topiramate for treating symptoms of bipolar mania (an illness with periods of elation, excessive excitement, irritability, high energy, racing thoughts, poor sleep, poor judgment, reckless beha...
What is the current status of trial NCT00550394?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 56 participants. The study started on 2008-04. Estimated completion is 2010-06.
What interventions are being tested in trial NCT00550394?
The interventions under investigation include: Quetiapine and Topiramate (DRUG), quetiapine and placebo (DRUG).
Who is sponsoring clinical trial NCT00550394?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.